KIPF announces mandatory squeeze-out of Pelion shares

The main shareholder of the WSE-listed pharma group Pelion, KIPF announced a mandatory buyout of 11.95 percent free float shares at PLN 59.04 price apiece. The redemption date was set for June 13. Back in March, KIPF announced a tender to buy back 45.24 percent shares of the company, and managed to buy 37.9 percent stake at PLN 59.04 per share for a total price tag of PLN 488.3 million.